Surf Bio, Inc.

PALO ALTO, CA · Founded 2021 · CIK 0001921739 · Biotech · Acquired

Novel biotechnology platform for developing enhanced therapeutics

surf.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$16M
1 Form D · Apr 2022
54 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$16,024,990
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2473Kestrel Therapeutics Inc.—$21M
2474FIBRONOX, L.L.C.——
2475Aulos Bioscience, Inc.—$20M
2476Surf Bio, Inc.—$16M
2477ImmunGene——
2478MABVAX THERAPEUTICS INC—$16M
2479INGENUITY SYSTEMS INC—$15M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Ben AskewDirector
  • Lindy FishburneDirector
  • Bryan MazlishDirector · Executive Officer
  • Jennifer SchneiderDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.